SONA.CN - Sona Nanotech Inc.

Canadian Sec - Canadian Sec Delayed Price. Currency in CAD
2.7800
+0.0600 (+2.21%)
At close: 3:59PM EDT
Stock chart is not supported by your current browser
Previous Close2.7200
Open2.7200
Bid2.7600 x 0
Ask2.8500 x 0
Day's Range2.5500 - 2.9500
52 Week Range0.0100 - 3.8000
Volume459,049
Avg. Volume806,901
Market Cap167.496M
Beta (5Y Monthly)N/A
PE Ratio (TTM)N/A
EPS (TTM)-0.0450
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • CNW Group

    IIROC Trade Resumption - SONA

    IIROC Trade Resumption - SONA

  • Sona Nanotech Comments on Trading Activity at Request of IIROC
    Newsfile

    Sona Nanotech Comments on Trading Activity at Request of IIROC

    Halifax, Nova Scotia--(Newsfile Corp. - June 1, 2020) - Sona Nanotech Inc. (CSE: SONA), (OTCQB: SNANF) (the "Company") has been requested by the Investment Industry Regulatory Organization of Canada (IIROC) to comment on the recent increase in the trading volume and price of the Company's common shares. The Company is not aware of any material change in its business or affairs that has not been publicly disclosed that would account for the recent increase ...

  • CNW Group

    IIROC Trading Halt - SONA

    VANCOUVER , June 1, 2020 /CNW/ - The following issues have been halted by IIROC: Company: Sona Nanotech Inc. CSE Symbol: SONA Reason: Single-Stock Circuit Breaker Halt Time (ET): 9:34:45 AM IIROC can make ...

  • Sona Nanotech Engages MRIGlobal for COVID-19 Test Validation Studies
    Newsfile

    Sona Nanotech Engages MRIGlobal for COVID-19 Test Validation Studies

    Halifax, Nova Scotia--(Newsfile Corp. - May 22, 2020) -  Sona Nanotech Inc. (CSE: SONA) (OTCQB: SNANF) (the "Company") is pleased to announce the engagement of MRIGlobal, a leading applied scientific research organization, to provide analytical and clinical validation studies for Sona's COVID-19 rapid detection, point-of-care, antigen test which will be used for submission to Health Canada for regulatory approval and the FDA for Emergency Use Authorization (EUA). MRIGlobal has three ISO 9001, CLIA ...

  • Sona Nanotech Provides COVID-19 Antigen Test Progress Update
    Newsfile

    Sona Nanotech Provides COVID-19 Antigen Test Progress Update

    Halifax, Nova Scotia--(Newsfile Corp. - May 12, 2020) - Sona Nanotech Inc. (CSE: SONA), (OTCQB: SNANF) (the "Company") is pleased to provide the following update on the development of its rapid-response, COVID-19 antigen test. The Company received confirmation from an independent laboratory that its test achieved a positive response to a recombinant whole spike protein control reagent specific to SARS-CoV2 and matched the limit of detection (LOD) achieved in its own labs. ...

  • Sona Nanotech Provides a Progress Update on its Covid-19 Antigen Test
    Newsfile

    Sona Nanotech Provides a Progress Update on its Covid-19 Antigen Test

    Halifax, Nova Scotia--(Newsfile Corp. - April 13, 2020) -  Sona Nanotech Inc. (CSE: SONA) (OTC PINK: SNANF) (the "Company") is pleased to provide an update on the development, manufacturing arrangements and pre-orders for its Covid-19 antigen test. The Company this past week has: Progressed from feasibility and prototype testing to the optimization stage for its Covid-19 antigen rapid response test;Commenced work with two, third-party laboratories to prepare validation protocols; Signed a memorandum of ...

  • Sona Nanotech Awarded $4.1 Million from NGen for Rapid Development and Launch of COVID-19 Antigen Test
    Newsfile

    Sona Nanotech Awarded $4.1 Million from NGen for Rapid Development and Launch of COVID-19 Antigen Test

    Halifax, Nova Scotia--(Newsfile Corp. - March 31, 2020) - Sona Nanotech Inc. (CSE: SONA) (OTC Pink: SNANF) (the "Company") is pleased to announce that it has been awarded a $4.1 million grant from NGen, Canada's Advanced Manufacturing Supercluster, to develop and commercialize its Covid-19 rapid-response antigen test. This non-repayable grant will be used to accelerate the development of a prototype and scale manufacturing capabilities with a view to deploying this Covid-19 virus-detecting, point-of-care ...

  • Sona Nanotech Enters into a Manufacturing Service Agreement and a Sale Letter of Intent Agreement for 2mm Tests
    Newsfile

    Sona Nanotech Enters into a Manufacturing Service Agreement and a Sale Letter of Intent Agreement for 2mm Tests

    Halifax, Nova Scotia--(Newsfile Corp. - March 30, 2020) - Sona Nanotech Inc. (CSE: SONA), (OTC Pink: SNANF) (the "Company") entered into service and supply agreements with a contract manufacturing organization (CMO) in Europe for the manufacture of its Covid-19 virus-detecting, rapid-response test. The Company also entered into a letter of intent agreement with an international distributor representing the health authority of a G20 country for the purchase of 2,000,000 test kits. The ...

  • Sona Nanotech Obtains New OTC Trading Symbol
    Newsfile

    Sona Nanotech Obtains New OTC Trading Symbol

    Halifax, Nova Scotia--(Newsfile Corp. - March 20, 2020) - Sona Nanotech Inc. (CSE: SONA) (OTC Pink: SNANF) (the "Company") is pleased to announce that it has undertaken to further develop the U.S. trading market for its common shares. As a first step, Sona recently applied for a new OTC trading symbol that will more accurately reflect the company's current name and business. At the market open today, the symbol was changed from "LMTCF" to ...

  • RETRANSMISSION: Sona Achieves Significant Milestone in Covid-19 Test Development
    Newsfile

    RETRANSMISSION: Sona Achieves Significant Milestone in Covid-19 Test Development

    Halifax, Nova Scotia--(Newsfile Corp. - March 19, 2020) - Sona Nanotech Inc. (CSE: SONA) (OTC PINK: LMTCF) ("Sona") is pleased to provide an update on the development of its rapid-response Covid-19 test. Sona is leading a consortium of diagnostic test developers including GE Healthcare Life Sciences, to create a rapid-response, lateral flow test that will directly identify the Covid-19 virus and provide in-field test results in minutes, without the use of specialized ...

  • Sona Achieves Significant Milestone in Covid-19 Test Development
    Newsfile

    Sona Achieves Significant Milestone in Covid-19 Test Development

    Halifax, Nova Scotia--(Newsfile Corp. - March 18, 2020) - Sona Nanotech Inc. (CSE: SONA) (OTC Pink: LMTCF) ("Sona") is pleased to provide an update on the development of its rapid-response Covid-19 test. Sona is leading a consortium of diagnostic test developers including GE Healthcare Life Sciences, to create a rapid-response, lateral flow test that will directly identify the Covid-19 virus and provide in-field test results in minutes, without the use of specialized ...

  • Sona Nanotech Grants Options
    Newsfile

    Sona Nanotech Grants Options

    Halifax, Nova Scotia--(Newsfile Corp. - March 17, 2020) - Sona Nanotech Inc. (CSE: SONA) (the "Company") is pleased to announce that it has granted 1,100,000 incentive stock options under the Company's Stock Option Plan ("Option Plan") of which 550,000 have been granted to Directors and Officers. Each option is exercisable into one common share at a price of $0.60 per share and will vest at the rate of 25% every six months. The ...

  • Sona Provides Corporate Update
    Newsfile

    Sona Provides Corporate Update

    Halifax, Nova Scotia--(Newsfile Corp. - March 12, 2020) - Sona Nanotech Inc. (CSE: SONA) (OTC Pink: LMTCF) ("Sona") is pleased to provide a corporate update on recent activities. In the past several weeks, Sona has been focused on work related to the development of a rapid response COVID-19 lateral flow test. This update will outline progress and advancements on Sona's COVID-19 test and other corporate developments.The Sona Advantage Sona is a research and development ...

  • Sona Provides Update on Coronavirus Rapid Screening Test and Announces Scientific Advisors
    Newsfile

    Sona Provides Update on Coronavirus Rapid Screening Test and Announces Scientific Advisors

    Halifax, Nova Scotia--(Newsfile Corp. - March 6, 2020) - Sona Nanotech Inc. (CSE: SONA) (OTC: LMTCF) ("Sona") is pleased to provide an update on its Covid-19 rapid screening test as well as announcing the addition of Fiona Marshall and Sandy Morrison as scientific advisors for the Covid-19 test development.Fiona Marshall will assist the Sona team with scientific considerations of test development, manufacturing set-up, quality control and regulatory approval. Ms. Marshall is the current ...

  • Sona Partners With GE Healthcare Life Sciences to Complete Coronavirus Rapid Screening Test
    Newsfile

    Sona Partners With GE Healthcare Life Sciences to Complete Coronavirus Rapid Screening Test

    Halifax, Nova Scotia--(Newsfile Corp. - March 4, 2020) - Sona Nanotech Inc. (CSE: SONA) (OTC PINK: LMTCF) ("Sona") and GE Healthcare Life Sciences will jointly complete test development of the Sona Covid-19 Coronavirus rapid response lateral flow test, and will use GE Healthcare Life Sciences' Fast Flow High Performance Membrane (FFHP) in production of the test. Sona will retain all commercial rights to the resulting test.The companies will work in parallel to complete ...

  • Sona Announces Data Partnership for Covid-19 Rapid Screening Test
    Newsfile

    Sona Announces Data Partnership for Covid-19 Rapid Screening Test

    Halifax, Nova Scotia--(Newsfile Corp. - February 18, 2020) - Sona Nanotech Inc. (CSE: SONA) has announced a partnership with UK-based medical technology company Bond Digital Health (Bond) to add data capture and analysis to its coronavirus (Covid-19) rapid screening test currently in development.This data partnership will allow test result data to be collected through either a reader system or mobile app before being securely stored in the cloud. The data can be accessed ...

  • Sona announces key partner for Coronavirus Rapid Screening Test
    Newsfile

    Sona announces key partner for Coronavirus Rapid Screening Test

    Halifax, Nova Scotia--(Newsfile Corp. - February 13, 2020) - Sona Nanotech Inc.  (CSE: SONA)  ("Sona") has secured an agreement with The Native Antigen Company ("Native") to supply biologics for the recently announced Covid-19 Coronavirus rapid screening test, currently in development by Sona (See Sona news release dated February 10, 2020).Native is a leading supplier of native and recombinant antigens for emerging and endemic infectious diseases. Native is one of the first recognised suppliers to ...

  • Sona Develops Rapid Screening Test for Coronavirus
    Newsfile

    Sona Develops Rapid Screening Test for Coronavirus

    Halifax, Nova Scotia--(Newsfile Corp. - February 10, 2020) - Sona Nanotech Inc. ("Sona") (CSE: SONA) is deploying its proprietary nanotechnology in the development of a rapid screening test for the current Coronavirus, "nCoV19". Sona is developing a quick-response lateral flow test to screen patients for the nCoV19 virus. When completed, the test is expected to produce results in 5-15 minutes and is anticipated to cost less than $50. There is currently no lateral ...

  • Sona Announces Conversion of Notes Payable
    Newsfile

    Sona Announces Conversion of Notes Payable

    Halifax, Nova Scotia--(Newsfile Corp. - January 14, 2020) - Sona Nanotech Inc. (CSE: SONA) ("Sona" or the "Company"): The Company is converting notes payable of $95,000 and accrued interest of $67,322 owed to certain non-arm's length note holders and notes payable of $200,000 and accrued interest of $141,732 owed to certain arm's length note holders. The notes payable will be settled in full by the issuance to these note holders of ...

  • Sona Nanotech Appoints New Director
    Newsfile

    Sona Nanotech Appoints New Director

    Halifax, Nova Scotia--(Newsfile Corp. - December 19, 2019) - Sona Nanotech Inc. (CSE: SONA) (the "Company") is pleased to announce the appointment of Mr. Jim Megann to the Company's Board of Directors. Mr. Megann is a former director of the Company and is currently the Managing Director of Numus Financial. Numus Financial has been an investor in Sona Nanotech since 2014.Mr. Megann is replacing Mr. Wade Dawe, who has served on the ...

  • CNW Group

    Antler Gold announces closing of the purchase of mineral assets from Sona Nanotech

    HALIFAX, Aug. 16, 2019 /CNW/ - Antler Gold Inc. ("Antler") (TSXV:ANTL.V - News) and Sona Nanotech Inc. ("Sona") (CSE:SONA.CN - News) are pleased to announce that Antler has acquired from Sona a 100% interest in certain mineral claims comprising the Crescent Lake/KM61 molybdenum-copper-silver project located in Armstrong, Ontario (the "Property"), as announced in a press release dated May 15, 2019. Antler acquired the Property (the "Transaction") in consideration of the assumption of all liabilities of Sona associated with the Property and the future payment to Sona of contingent consideration if Antler disposes of the Property to a third party, or enters into an agreement or arrangement with a third party to otherwise monetize the Property by way of joint venture, option or other form of transaction (a "Future Transaction").

  • Newsfile

    Sona Nanotech Inc. and Expedeon AG Strengthen Partnership to Improve Global Market Offering

    Diagnostics companies sign new commercial agreement to address limitations in development of multiplex point-of-care lateral flow assay diagnostic tests Halifax, Nova Scotia--(Newsfile Corp. - August 6, 2019) - Sona Nanotech Inc. (CSE: SONA) and Expedeon AG (FSE: EXN) (ISIN: DE000A1RFM03), today announced they have entered into a commercial agreement to address limitations in development of complex, multiplex point-of-care (POC) lateral flow assay (LFA) diagnostic tests.Under the terms of the agreement, Expedeon will provide gold nanoparticle, ...

  • Sona Announces Debt Settlements with Creditors
    Newsfile

    Sona Announces Debt Settlements with Creditors

    Halifax, Nova Scotia--(Newsfile Corp. - July 16, 2019) - Sona Nanotech Inc. (CSE: SONA) ("Sona" or the "Company") has arranged a debt settlement of $797,953 in amounts owed to certain non-arm's length creditors and included in accounts payable to related parties in the financial statements of Sona (the "Debts"). The Debts will be settled in full by the issuance to these creditors of an aggregate of 3,199,812 common shares at a deemed price ...

  • CNW Group

    Antler Purchases Subsidiaries from Sona Nanotech

    HALIFAX , June 14, 2019 /CNW/ - Antler Gold Inc. (" Antler ") (TSXV: ANTL) and Sona Nanotech Inc. (" Sona ") (CSE: SONA) are pleased to announce that they have closed Antler's acquisition ...